William Dalton

Dr William Dalton

CEO, M2Gen, & Director, The DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center

Dr. William (Bill) Dalton serves as Founder and CEO of M2Gen, a health informatics solutions company, focused on accelerating the discovery, development and delivery of personalized medicine.  Before taking this role, he was the President and CEO of Moffitt Cancer Center from 2002 to 2012.  He is interested in the development of personalized cancer care and patient-centered outcomes research and developing evidence-based, personalized cancer treatments and information/decision tools for patients and clinicians. In 2014, the Moffitt Cancer Center, in partnership with the James Cancer Center at the Ohio State University, founded the cancer center alliance called ORIEN, Oncology Research Information and Exchange Network, with the goal of accelerating cancer research discovery by sharing information and delivering hope through collaborative learning and partnerships.  There are currently fifteen cancer centers that have joined ORIEN. Dr. Dalton is the past-Chair of the Personalized Medicine Coalition and current Chair of the Institute of Human and Machine Cognition. He has over 200 publications and has numerous patents in the fields of drug discovery and computer/information networking.


Featured Speakers



evidera excelra genrubix signet at big data stemtrak

The event is a good opportunity for industry to come together and identify ways to understand and utilize big data in the advancement of patient care.

Dr Mark Roche, CEO, Avanti iHealth

Show the sponsors

Vote who is making waves in the industry!

Phacilitate will gather influencers and industry innovators together from across healthcare, academia, Big Pharma, government and technology innovators into an ebook. Find out more